Favipiravir pharmacokinetics in ebola-infected patients of the jiki trial reveals concentrations lower than targeted

HIGHLIGHTS

• who: Thi Huyen Tram Nguyen and collaborators from the 8, Laboratoire , Jean Mérieux, Lyon, France Editor: WHorby, University of Oxford have published the paper: Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted, in the Journal: (JOURNAL) of February/23,/2017
• what: The authors report the favipiravir plasma concentrations that were achieved in participants in the JIKI trial and put them in perspective with the model-based targeted concentrations. Using this model a dosing regimen of 1,200 mg every twelve hours was proposed for the maintenance dose . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.